Evidence map›Paper›PMID 32557399›Full record

ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2022

The Development and Evaluation of a Patient Educational Resource for Cancer-Related Cognitive Dysfunction.

Eleenor H Abraham, Bilal Khan, Erick Ling, Lori J Bernstein

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Eleenor H AbrahamDepartment of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Bilal KhanDepartment of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Erick LingDepartment of Medicine, University of Toronto, Toronto, Canada.
Lori J BernsteinDepartment of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. Lori.Bernstein@uhn.ca.ORCID 0000-0002-2479-3223
University Health Network · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer patients and survivors frequently experience cognitive deficits, including problems with attention and memory. These symptoms, referred to as cancer-related cognitive dysfunction (CRCD), are associated with distress. Learning about CRCD and self-management strategies may improve functioning and quality of life in cancer survivors. This study describes the development and evaluation of a CRCD resource for cancer patients. An educational booklet was developed in accordance with multiple evidence-based guidelines for cancer patient education. Cancer patients on chemotherapy (N = 113; 34% men; median age 55, range 19-85) reviewed the booklet and self-reported CRCD knowledge before and after reading the booklet. They also gave ratings on general impressions of the booklet. Seventy-five percent of participants reported that the resource increased their self-reported CRCD knowledge. A Wilcoxon signed-rank test demonstrated that exposure to the booklet elicited a statistically significant change in self-reported knowledge (Z = - 7.13, p < 0.001). A repeated-measures ANCOVA determined that the means of self-reported CRCD knowledge were significantly different between pre- and post-exposure (F(1, 92) = 7.96, p = 0.006, η

Indexed as

Cancer SurvivorsCognitive DysfunctionNeoplasmsFemaleHumansMaleMiddle AgedPamphletsQuality of LifeSurvivorsCancer-related brain fogCancer-related cognitive impairmentCancer survivorshipChemobrainPatient educationSymptom management

Identifiers

PMID32557399
OpenAlexW3036772340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.